Department of Surgery, Indiana University, Indianapolis, IN, USA.
J Natl Cancer Inst. 2010 Aug 4;102(15):1178-87. doi: 10.1093/jnci/djq215. Epub 2010 Jun 23.
The disparity in breast cancer mortality between African American women and non-Hispanic white women has been the subject of increased scrutiny. Few studies have addressed these differences in the setting of equal access to health care. We compared the breast cancer outcomes of underinsured African American and non-Hispanic white patients who were treated at a single institution.
We conducted a retrospective review of medical records for breast cancer patients who were treated at Wishard Memorial Hospital from January 1, 1997, to February 28, 2006. A total of 574 patients (259 non-Hispanic whites and 315 African Americans) were evaluated. A Cox proportional hazards regression analysis for competing risks was performed. All statistical tests were two-sided.
Sociodemographic characteristics were similar in the two groups, and both racial groups were equally unlikely to have undergone screening mammography during the 2 years before diagnosis. Most (84%) of the patients were underinsured. The median time from diagnosis to operation, receipt of adequate surgery, and use of all types of adjuvant therapy were similar in the two groups. Median follow-up was 80.3 months for non-Hispanic whites and 77.9 months for African Americans. After accounting for the effect of comorbidities, African American race was statistically significantly associated with breast cancer-specific mortality (African Americans vs non-Hispanic whites: 26.0% vs 17.5%, P = .028; hazard ratio [HR] of death = 1.64, 95% confidence interval [CI] = 1.06 to 2.55). Adjustment for age at diagnosis, clinical stage, and hormone receptor status attenuated the effect, and the effect of race on breast cancer-specific survival was no longer statistically significant (HR of death from breast cancer = 1.43, 95% CI = 0.89 to 2.30). After adjustment for sociodemographic factors, the hazard ratio for race was further attenuated (HR = 1.26; 95% CI = 0.79 to 2.00).
In this underinsured population, African American patients had poorer breast cancer-specific survival than non-Hispanic white patients. After adjustment for clinical and sociodemographic factors, the effect of race on survival was no longer statistically significant.
非裔美国女性和非西班牙裔白种女性之间乳腺癌死亡率的差异一直受到越来越多的关注。很少有研究在获得同等医疗保健的情况下解决这些差异。我们比较了在一家机构接受治疗的保险不足的非裔美国人和非西班牙裔白种女性乳腺癌患者的乳腺癌结局。
我们对 1997 年 1 月 1 日至 2006 年 2 月 28 日期间在威沙特纪念医院接受治疗的乳腺癌患者的病历进行了回顾性审查。共评估了 574 名患者(259 名非西班牙裔白人和 315 名非裔美国人)。进行了竞争风险的 Cox 比例风险回归分析。所有统计检验均为双侧检验。
两组的社会人口统计学特征相似,两组都同样不太可能在诊断前的 2 年内接受筛查乳房 X 光检查。大多数(84%)患者保险不足。两组从诊断到手术、接受充分手术以及使用所有类型辅助治疗的中位时间相似。非西班牙裔白人的中位随访时间为 80.3 个月,非裔美国人的中位随访时间为 77.9 个月。在考虑到合并症的影响后,非裔美国人种族与乳腺癌特异性死亡率呈统计学显著相关(非裔美国人与非西班牙裔白人:26.0%比 17.5%,P =.028;死亡风险比[HR]为 1.64,95%置信区间[CI]为 1.06 至 2.55)。调整诊断时的年龄、临床分期和激素受体状态减弱了这种影响,种族对乳腺癌特异性生存的影响不再具有统计学意义(死于乳腺癌的 HR = 1.43,95%CI = 0.89 至 2.30)。调整社会人口统计学因素后,种族的风险比进一步减弱(HR = 1.26;95%CI = 0.79 至 2.00)。
在这个保险不足的人群中,非裔美国患者的乳腺癌特异性生存率低于非西班牙裔白种患者。在调整临床和社会人口统计学因素后,种族对生存的影响不再具有统计学意义。